INS and obesity due to melanocortin 4 receptor deficiency: Insulin sensitivity, measured as insulin-stimulated GDR, was reduced in individuals with type 2 diabetes compared with the glucose-tolerant individuals with obesity (31–48%) and lean individuals (41–58%) in all studies (all p<0.05), and in individuals with obesity vs lean individuals (18%) in study I (p<0.05).